Sanders Morris Harris’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,600
Closed -$1.03M 240
2026
Q1
$1.03M Buy
+4,600
New +$1.15M 0.16% 116
2025
Q4
Sell
-4,600
Closed -$1.26M 245
2025
Q3
$1.26M Buy
+4,600
New +$1.26M 0.17% 86
2025
Q2
Sell
-4,600
Closed -$1.02M 279
2025
Q1
$1.02M Hold
4,600
0.16% 85
2024
Q4
$1.05M Hold
4,600
0.16% 97
2024
Q3
$1.12M Hold
4,600
0.19% 79
2024
Q2
$881K Hold
4,600
0.14% 98
2024
Q1
$911K Hold
4,600
0.17% 96
2023
Q4
$794K Hold
4,600
0.39% 67
2023
Q3
$670K Hold
4,600
0.14% 115
2023
Q2
$987K Buy
+4,600
New +$1.03M 0.22% 63
2023
Q1
Sell
-4,600
Closed -$957K 231
2022
Q4
$957K Hold
4,600
0.36% 54
2022
Q3
$1.03M Hold
4,600
0.25% 61
2022
Q2
$992K Hold
4,600
0.22% 69
2022
Q1
$1.12M Hold
4,600
0.22% 76
2021
Q4
$1.19M Hold
4,600
0.21% 79
2021
Q3
$1.18M Hold
4,600
0.21% 82
2021
Q2
$1.14M Hold
4,600
0.22% 87
2021
Q1
$907K Hold
4,600
0.19% 95
2020
Q4
$996K Hold
4,600
0.23% 80
2020
Q3
$812K Buy
+4,600
New +$849K 0.22% 94
2020
Q2
Sell
-18,758
Closed -$2.93M 192
2020
Q1
$2.93M Buy
18,758
+758
+4% +$121K 2.86% 8
2019
Q4
$2.81M Hold
18,000
0.64% 34
2019
Q3
$2.32M Hold
18,000
0.56% 40
2019
Q2
$2.21M Buy
+18,000
New +$1.99M 0.57% 40

Other funds holding RMD

Sanders Morris Harris's RMD Position: Q2 2026 in Review

Sanders Morris Harris sold out of ResMed (RMD) in Q2 2026, closing a stake of 4,600 shares — an estimated $1.03M sold.

Sanders Morris Harris first reported a position in RMD in Q2 2019 and held it in 24 quarters. The position peaked at $2.93M in Q1 2020. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Sanders Morris Harris reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Sanders Morris Harris sold 4,600 ResMed shares in Q2 2026, an estimated $1.03M.
  • Sanders Morris Harris first reported a position in ResMed in Q2 2019 and held it in 24 quarters.
  • Sanders Morris Harris's ResMed position peaked at $2.93M in Q1 2020.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.